Richmond Pharmacology is one of Europe's leading Early Phase Full-Service CROs. Our reputation has been gained through the conduct of over 250 Early Phase Studies over the past decade. Our wide ranging experience is complemented by our specialist focus on FTIH, TQT, Bridging Studies and Patient Studies.
Under the same senior management for the last decade, Richmond Pharmacology offers the continuity of a highly specialised medical team that has worked closely with its UK NHS partners to ensure a safe environment for our patients and volunteers whilst we remain at the forefront of early phase clinical research.
August 2001 - Richmond Pharmacology is co-founded by Dr Ulrike Lorch, Dr Jörg Täubel and
Dr Radivoj Arezina
September 2001 - Clinical trials unit established in Atkinson Morley's Hospital, Wimbledon
January 2002 - Dr Jörg Täubel joins Richmond Pharmacology as Managing Director
October 2002 - Second unit opened at Atkinson Morley Hospital expanding to 52 beds and over 50 staff
November 2003 - Plans revealed for expansion to include a unit at St George's University London to become the largest privately owned CRO in the UK
December 2003 - Doors open at the new 32 bed unit in St George's University Hospital
December 2004 - Introduction of a dedicated Japanese Recruitment team
May 2005 - Richmond Pharmacology becomes the UK's First CRO to be based in 2 Acute NHS Teaching Hospitals opening a second new facility at Mayday University Hospital in Croydon, London
August 2005 - Richmond Pharmacology celebrate 5 years of clinical trials
August 2006 - Richmond Pharmacology launches its new volunteer recruitment website www.trials4us.com
October 2007 - Richmond Pharmacology hosts pre-conference workshop for QT & Safety Pharmacology Strategy Congress 2007
October 2008 - Awarded MHRA Standard and Supplementary Accreditation for 2 hospital based Clinical Trial Centres.
April 2009 - Richmond Pharmacology is the FIRST and ONLY Clinical Research Organisation to become part of the UKCRC Experimental Medicines Resources Network
April 2010 - Richmond Pharmacology's volunteer database exceeds 100,000 records
November 2010 - Richmond Pharmacology announce partnership with ACRONET (Japan based CRO)
March 2011 - TQT Levofloxacin Study Uncovers New Results
August 2011 - Richmond Pharmacology celebrates 10 years of clinical excellence
Richmond Pharmacology will carry out clinical studies to the highest ethical and medical standards. We will use latest information technology systems to ensure fast and accurate capture and processing of data. Our volunteer recruitment team will lead the industry by applying professional strategies and techniques to recruit study participants and deliver a predictable cost outcome ratio.
Our staff will be the best in their area. They will be attentive and thorough in their attitude to the research participants ensuring the highest safety standards. They will deliver a professional and courteous service and establish long-term working relationships with our clients.
Expertise combined with attention to detail and efficiency will result in accurate and meaningful research data produced in the shortest time possible. As a research organisation run by healthcare professionals we thrive to make a meaningful contribution towards medicine, interacting with healthy research volunteers, patients, patient groups, clinical and academic specialists in their respective fields, to ensure our research meets the highest regulatory, scientific and ethical requirements.
Our specialist experience includes:
- First Time Into Human Studies
- TQT Studies
- Japanese and Japanese Bridging Studies
- Patient Recruitment
- Adaptive Study Design (Umbrella Protocols)
- Ascending Single- and Multiple Dose (SAD and MAD) Studies
- Drug Interaction Studies
- Bioequivalence
- Phase IIa, Proof of Concept
- Bioanalytical and biomarker
- Dedicated therapeutic expertise
Full Service Offering:
- Protocol Writing & CRF Design
- Regulatory Applications
- Data Management
- Pharmacy
- Laboratory
- Drug Free Plasma
- In House Volunteer Catering
For further information on our Phase I/II specialist services and expertise contact Richmond Pharmacology Business Development on info@richmondpharmacology.com
